Showing 881 - 900 results of 113,630 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( 10 ((nm decrease) OR (we decrease)) ))', query time: 1.22s Refine Results
  1. 881

    Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells by Tadeja Kuret (5059433)

    Published 2018
    “…<div><p>Serum amyloid A (SAA) is a sensitive inflammatory marker rapidly increased in response to infection, injury or trauma during the acute phase. …”
  2. 882
  3. 883
  4. 884

    Statistical details of data presented in Fig 16. by Piotr Popik (292215)

    Published 2024
    “…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”
  5. 885

    Statistical details of data presented in Fig 17. by Piotr Popik (292215)

    Published 2024
    “…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”
  6. 886

    Simon Nilsson’s polygon features in action. by Piotr Popik (292215)

    Published 2024
    “…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”
  7. 887

    The ATR IR signal decreases with decreasing dilutions of cells. by Allison L. Stelling (392086)

    Published 2013
    “…<p>Shown is a box plot for serial dilutions of a glioblastoma cell suspension. …”
  8. 888
  9. 889

    Stable Silencing of <i>MAGE-C1/CT7</i> expression in myeloma cell line SKO-007 transduced with pRS-shRNA-<i>MAGE-C1/CT7</i> also leads to cell cycle changes when treated with 10 nM... by Fabricio de Carvalho (195896)

    Published 2011
    “…In G2/M phase, bortezomib-treated and inhibited cells had lower percentage (48%) of PI stained cells when compared with control cells (empty vector [13%] and ineffective shRNA [9%]) [10 nM bortezomib by 48 h] (**p<0.01). The number of dead cells (Sub-G1) was higher in bortezomib-treated and inhibited (shRNA-<i>MAGE-C1/CT7</i>) cells when compared with controls (empty vector and ineffective shRNA), but this difference was not statistically significant. …”
  10. 890
  11. 891
  12. 892
  13. 893

    Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases by Xiao Li (107004)

    Published 2022
    “…Compared to the type I PRMT inhibitor from our previous work (DCPR049_12), ZL-28-6 showed increased potency against CARM1 and decreased activity against other type I PRMTs. Moreover, ZL-28-6 showed better antiproliferation activities toward a series of solid tumor cells than DCPR049_12, indicating its broad spectrum of anticancer activity. …”
  14. 894

    Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

    Published 2013
    “…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”
  15. 895
  16. 896
  17. 897
  18. 898
  19. 899
  20. 900